相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cancer Statistics, 2012
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2012)
Metformin Inhibits Cell Proliferation, Migration and Invasion by Attenuating CSC Function Mediated by Deregulating miRNAs in Pancreatic Cancer Cells
Bin Bao et al.
CANCER PREVENTION RESEARCH (2012)
Chronic GLP-1 Receptor Activation by Exendin-4 Induces Expansion of Pancreatic Duct Glands in Rats and Accelerates Formation of Dysplastic Lesions and Chronic Pancreatitis in the KrasG12D Mouse Model
Belinda Gier et al.
DIABETES (2012)
Steps Toward the Meaningful Translation of Prevention Strategies for Type 2 Diabetes
William T. Cefalu
DIABETES CARE (2012)
Cancer occurrence in Danish diabetic patients: duration and insulin effects
B. Carstensen et al.
DIABETOLOGIA (2012)
Diabetes, Metformin, and Breast Cancer in Postmenopausal Women
Rowan T. Chlebowski et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Diabetes mellitus correlates with increased risk of pancreatic cancer: A population-based cohort study in Taiwan
Kuan-Fu Liao et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2012)
Diabetes and pancreatic cancer
Donghui Li
MOLECULAR CARCINOGENESIS (2012)
Genes Related to Diabetes May Be Associated With Pancreatic Cancer in a Population-Based Case-Control Study in Minnesota
Anna E. Prizment et al.
PANCREAS (2012)
New-onset diabetes in pancreatic cancer: A study in the primary care setting
Gaurav Aggarwal et al.
PANCREATOLOGY (2012)
Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals
Meei-Shyuan Lee et al.
BMC CANCER (2011)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
PDX-1 Demonstration of Oncogenic Properties in Pancreatic Cancer
Shi-He Liu et al.
CANCER (2011)
Diabetes and risk of pancreatic cancer: a pooled analysis of three large case-control studies
Donghui Li et al.
CANCER CAUSES & CONTROL (2011)
Association study of type 2 diabetes genetic susceptibility variants and risk of pancreatic cancer: an analysis of PanScan-I data
Brandon L. Pierce et al.
CANCER CAUSES & CONTROL (2011)
Diagnosis and Classification of Diabetes Mellitus
DIABETES CARE (2011)
Reduced Risk of Colorectal Cancer With Metformin Therapy in Patients With Type 2 Diabetes A meta-analysis
Zhi-Jiang Zhang et al.
DIABETES CARE (2011)
Time-varying incidence of cancer after the onset of type 2 diabetes: evidence of potential detection bias
J. A. Johnson et al.
DIABETOLOGIA (2011)
Diabetes mellitus and risk of pancreatic cancer: A meta-analysis of cohort studies
Qiwen Ben et al.
EUROPEAN JOURNAL OF CANCER (2011)
Pancreatitis, Pancreatic, and Thyroid Cancer With Glucagon-Like Peptide-1-Based Therapies
Michael Elashoff et al.
GASTROENTEROLOGY (2011)
Pancreatic cancer and diabetes mellitus: A retrospective cohort study.
A. Yacoub et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Diabetes and Pancreatic Cancer Chicken or Egg?
J. Trent Magruder et al.
PANCREAS (2011)
Pancreatogenic Diabetes: Special Considerations for Management
YunFeng Cui et al.
PANCREATOLOGY (2011)
High Glucose Promotes Pancreatic Cancer Cell Proliferation via the Induction of EGF Expression and Transactivation of EGFR
Liang Han et al.
PLOS ONE (2011)
Novel Blood Biomarkers of Pancreatic Cancer-Associated Diabetes Mellitus Identified by Peripheral Blood-Based Gene Expression Profiles
Hai Huang et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
Past Medical History and Pancreatic Cancer Risk: Results From a Multicenter Case-Control Study
Patrick Maisonneuve et al.
ANNALS OF EPIDEMIOLOGY (2010)
Anthropometric Measures, Body Mass Index, and Pancreatic Cancer A Pooled Analysis From the Pancreatic Cancer Cohort Consortium (PanScan)
Alan A. Arslan et al.
ARCHIVES OF INTERNAL MEDICINE (2010)
Diabetes and Cancer: A Consensus Report
Edward Giovannucci et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
Cancer Statistics, 2010
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
Body mass index, effect modifiers, and risk of pancreatic cancer: a pooled study of seven prospective cohorts
Li Jiao et al.
CANCER CAUSES & CONTROL (2010)
Metabolic Factors and the Risk of Pancreatic Cancer: A Prospective Analysis of almost 580,000 Men and Women in the Metabolic Syndrome and Cancer Project
Dorthe Johansen et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
Crosstalk between Insulin/Insulin-like Growth Factor-1 Receptors and G Protein-Coupled Receptor Signaling Systems: A Novel Target for the Antidiabetic Drug Metformin in Pancreatic Cancer
Enrique Rozengurt et al.
CLINICAL CANCER RESEARCH (2010)
Insulin, Insulin Resistance, Obesity, and Cancer
Emily Jane Gallagher et al.
CURRENT DIABETES REPORTS (2010)
Pancreatic duct replication is increased with obesity and type 2 diabetes in humans
A. E. Butler et al.
DIABETOLOGIA (2010)
Diabetes therapy and cancer risk: causal effects and other plausible explanations
S. Hernandez-Diaz et al.
DIABETOLOGIA (2010)
Does Insulin Therapy Promote, Reduce, or Have a Neutral Effect on Cancers?
Hertzel C. Gerstein
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33
Gloria M. Petersen et al.
NATURE GENETICS (2010)
Obesity: Focus on all-cause mortality and cancer
Birgit Teucher et al.
MATURITAS (2010)
Sulphonylureas and cancer: a case-control study
Matteo Monami et al.
ACTA DIABETOLOGICA (2009)
Context-Dependent Transformation of Adult Pancreatic Cells by Oncogenic K-Ras
Sharon Y. Gidekel Friedlander et al.
CANCER CELL (2009)
Obesity and Cancer: The Role of Dysfunctional Adipose Tissue
Rob C. M. van Kruijsdijk et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
Inflammation and pancreatic cancer: an evidence-based review
Julia B. Greer et al.
CURRENT OPINION IN PHARMACOLOGY (2009)
Beneficial Endocrine but Adverse Exocrine Effects of Sitagliptin in the Human Islet Amyloid Polypeptide Transgenic Rat Model of Type 2 Diabetes Interactions With Metformin
Aleksey V. Matveyenko et al.
DIABETES (2009)
New Users of Metformin Are at Low Risk of Incident Cancer A cohort study among people with type 2 diabetes
Gillian Libby et al.
DIABETES CARE (2009)
Combined randomised controlled trial experience of malignancies in studies using insulin glargine
P. D. Home et al.
DIABETOLOGIA (2009)
Insulin glargine use and short-term incidence of malignancies-a population-based follow-up study in Sweden
J. M. Jonasson et al.
DIABETOLOGIA (2009)
The influence of glucose-lowering therapies on cancer risk in type 2 diabetes
C. J. Currie et al.
DIABETOLOGIA (2009)
Personalized Medicine for Pancreatic Cancer: A Step in the Right Direction
Andrew H. Ko et al.
GASTROENTEROLOGY (2009)
Antidiabetic Therapies Affect Risk of Pancreatic Cancer
Donghui Li et al.
GASTROENTEROLOGY (2009)
Metformin and Pathologic Complete Responses to Neoadjuvant Chemotherapy in Diabetic Patients With Breast Cancer
Sao Jiralerspong et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Metabolic Complications of Androgen Deprivation Therapy for Prostate Cancer
Philip J. Saylor et al.
JOURNAL OF UROLOGY (2009)
New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer
Rahul Pannala et al.
LANCET ONCOLOGY (2009)
Cancer Incidence and Mortality After Gastric Bypass Surgery
Ted D. Adams et al.
OBESITY (2009)
Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes
David M. Nathan et al.
DIABETES CARE (2009)
Temsirolimus safety profile and management of toxic effects in patients with advanced renal cell carcinoma and poor prognostic features
J. Bellmunt et al.
ANNALS OF ONCOLOGY (2008)
Is Pancreatic Diabetes (Type 3c Diabetes) Underdiagnosed and Misdiagnosed?
Philip D. Hardt et al.
DIABETES CARE (2008)
Rosiglitazone no longer recommended
[Anonymous]
LANCET (2008)
Prevalence and clinical profile of pancreatic cancer-associated diabetes mellitus
Rahul Pannala et al.
GASTROENTEROLOGY (2008)
Pancreatic cancer-associated diabetes mellitus: Prevalence and temporal association with diagnosis of cancer
Suresh T. Chari et al.
GASTROENTEROLOGY (2008)
Phase I, pharmacokinetic and pharmacodynamic study of the anti-insulinlike growth factor type 1 receptor monoclonal antibody CP-751,871 in patients with multiple myeloma
Martha Q. Lacy et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Bariatric surgery reduces cancer risk in morbidly obese patients
Nicolas V. Christou et al.
SURGERY FOR OBESITY AND RELATED DISEASES (2008)
The role of insulin receptors and IGF-I receptors in cancer and other diseases
Francesco Frasca et al.
ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY (2008)
Insulin and insulin-like growth factor signalling in neoplasia
Michael Pollak
NATURE REVIEWS CANCER (2008)
Temsirolimus, an mTOR inhibitor for treatment of patients with advanced renal cell carcinoma
Lois J. Malizzia et al.
CLINICAL JOURNAL OF ONCOLOGY NURSING (2008)
Effects of bariatric surgery on mortality in Swedish obese subjects
Lars Sjostrom et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Mechanisms and emerging treatments of the metabolic complications of chronic pancreatitis
Dana K. Andersen
PANCREAS (2007)
Growth hormone regulation of p85α expression and phosphoinositide 3-kinase activity in adipose tissue -: Mechanism for growth hormone-mediated insulin resistance
Juan-Pablo del Rincon et al.
DIABETES (2007)
Pancreatic cancer in type 1 and young-onset diabetes: systematic review and meta-analysis
R. J. Stevens et al.
BRITISH JOURNAL OF CANCER (2007)
The role of insulin receptor isoforms and hybrid Insulin/IGF-I receptors in human cancer
Antonino Belfiore
CURRENT PHARMACEUTICAL DESIGN (2007)
Pancreatic cancer-derived S-100A8 N-terminal peptide: A diabetes cause?
Daniela Basso et al.
CLINICA CHIMICA ACTA (2006)
Increased cancer-related mortality for patients with type 2 diabetes who use sulforrylureas or insulin
SL Bowker et al.
DIABETES CARE (2006)
In vitro and in vivo antitumor effects of the dual insulin-like growth factor-I/insulin receptor inhibitor, BMS-554417
P Haluska et al.
CANCER RESEARCH (2006)
Insulin, glucose, insulin resistance, and pancreatic cancer in male smokers
RZ Stolzenberg-Solomon et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Annual report to the Nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment
BK Edwards et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Type-II diabetes and pancreatic cancer:: a meta-analysis of 36 studies
R Huxley et al.
BRITISH JOURNAL OF CANCER (2005)
Metformin and reduced risk of cancer in diabetic patients
JMM Evans et al.
BMJ-BRITISH MEDICAL JOURNAL (2005)
Prevalence and determinants of exocrine pancreatic insufficiency among older adults:: Results of a population-based study
D Rothenbacher et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2005)
Tissue MicroArray analyses of pancreatic duodenal homeobox-1 in human cancers
XP Wang et al.
WORLD JOURNAL OF SURGERY (2005)
Fasting serum glucose level and cancer risk in Korean men and women
SH Jee et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Beta-cell function and insulin resistance evaluated by HOMA in pancreatic cancer subjects with varying degrees of glucose intolerance
ST Chari et al.
PANCREATOLOGY (2005)
Should pancreas imaging be recommanded in patients over 50 years when diabetes is discovered because of acute symptoms?
J Damiano et al.
DIABETES & METABOLISM (2004)
Diabetes status and post-load plasma glucose concentration in relation to site-specific cancer mortality: findings from the original Whitehall study
GD Batty et al.
CANCER CAUSES & CONTROL (2004)
Expression of connexin26 in islets of Langerhans is associated with impaired glucose tolerance in patients with pancreatic adenocarcinoma
F Pfeffer et al.
PANCREAS (2004)
Cancer incidence in patients with type 1 diabetes mellitus:: A population-based cohort study in Sweden
K Zendehdel et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Pancreatic-duodenal homeobox 1 regulates expression of liver receptor homolog 1 during pancreas development
JS Annicotte et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Exocrine pancreatic cancer, cigarette smoking, and diabetes mellitus: A case-control study in Northern Italy
L Bonelli et al.
PANCREAS (2003)
Increased PDX-1 expression is associated with outcome in patients with pancreatic cancer
M Koizumi et al.
SURGERY (2003)
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults
EE Calle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
WC Knowler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Physical activity, obesity, height, and the risk of pancreatic cancer
DS Michaud et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Pancreatic resection: Effects on glucose metabolism
LA Slezak et al.
WORLD JOURNAL OF SURGERY (2001)
Glucagon-like peptide-1 induces cell proliferation and pancreatic-duodenum homeobox-1 expression and increases endocrine cell mass in the pancreas of old, glucose-intolerant rats
R Perfetti et al.
ENDOCRINOLOGY (2000)
Physiological concentrations of insulin augment pancreatic cancer cell proliferation and glucose utilization by activating MAP kinase, PI3 kinase and enhancing GLUT-1 expression
XZ Ding et al.
PANCREAS (2000)
Insulinotropic glucagon-like peptide 1 agonists stimulate expression of homeodomain protein IDX-1 and increase islet size in mouse pancreas
DA Stoffers et al.
DIABETES (2000)
Early diagnosis and treatment of pancreatic dysplasia in patients with a family history of pancreatic cancer (vol 131, pg 247, 1999)
TA Brentnall et al.
ANNALS OF INTERNAL MEDICINE (2000)
The intracellular mechanism of insulin resistance in pancreatic cancer patients
J Liu et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2000)
分享论文
